Results 171 to 180 of about 50,141 (259)

The potential of spironolactone to mitigate the risk of nonalcoholic fatty liver disease in hypertensive populations: evidence from a cohort study

open access: hybrid
Di Shen   +10 more
openalex   +1 more source

Effect of spironolactone on diabetic nephropathy in albino rats: ultrastructural and immunohistochemical study

open access: diamond, 2017
Hassan M. Rezk   +5 more
openalex   +2 more sources

Malignant hypertension and pseudohyperaldosteronism associated with rifampicin therapy. [PDF]

open access: yesCardiovasc Diabetol Endocrinol Rep
Szedleski A   +4 more
europepmc   +1 more source

Finerenone: Extending MRAs Prognostic Benefit to the Recently Hospitalized and More Symptomatic Patient with HFpEF. [PDF]

open access: yesJ Clin Med
Tinti MD   +20 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy